- Home
- IMNN vs EVGN Comparison
IMNN vs EVGN Comparison
Compare IMNN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- EVGN
- Stock Information
- Founded
- IMNN 1982
- EVGN 1999
- Country
- IMNN United States
- EVGN Israel
- Employees
- IMNN N/A
- EVGN N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- IMNN Health Care
- EVGN Industrials
- Exchange
- IMNN Nasdaq
- EVGN Nasdaq
- Market Cap
- IMNN 15.1M
- EVGN 15.8M
- IPO Year
- IMNN 1985
- EVGN N/A
- Fundamental
- Price
- IMNN $1.01
- EVGN $2.96
- Analyst Decision
- IMNN Strong Buy
- EVGN Strong Buy
- Analyst Count
- IMNN 2
- EVGN 2
- Target Price
- IMNN $21.50
- EVGN $15.25
- AVG Volume (30 Days)
- IMNN 258.7K
- EVGN 22.5K
- Earning Date
- IMNN 11-12-2024
- EVGN 11-13-2024
- Dividend Yield
- IMNN N/A
- EVGN N/A
- EPS Growth
- IMNN N/A
- EVGN N/A
- EPS
- IMNN N/A
- EVGN N/A
- Revenue
- IMNN N/A
- EVGN $9,449,000.00
- Revenue This Year
- IMNN N/A
- EVGN $173.12
- Revenue Next Year
- IMNN N/A
- EVGN $33.10
- P/E Ratio
- IMNN N/A
- EVGN N/A
- Revenue Growth
- IMNN N/A
- EVGN 290.29
- 52 Week Low
- IMNN $0.48
- EVGN $2.29
- 52 Week High
- IMNN $3.65
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- IMNN 43.40
- EVGN 46.00
- Support Level
- IMNN $0.95
- EVGN $2.29
- Resistance Level
- IMNN $1.21
- EVGN $3.32
- Average True Range (ATR)
- IMNN 0.07
- EVGN 0.26
- MACD
- IMNN 0.00
- EVGN 0.10
- Stochastic Oscillator
- IMNN 23.08
- EVGN 65.05
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.